These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 10386037)
21. Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma. Scholz A; Rehm VA; Rieke S; Derkow K; Schulz P; Neumann K; Koch I; Pascu M; Wiedenmann B; Berg T; Schott E Am J Gastroenterol; 2007 Nov; 102(11):2471-81. PubMed ID: 17581268 [TBL] [Abstract][Full Text] [Related]
22. Clinical value of urinary and serum pseudouridine in diagnosis and monitoring of primary liver cancer. Tu Z; Xu S; Wu M Chin Med J (Engl); 1995 Mar; 108(3):204-8. PubMed ID: 7796629 [TBL] [Abstract][Full Text] [Related]
24. Increased levels of typically fetal bile acid species in patients with hepatocellular carcinoma. El-Mir MY; Badia MD; Luengo N; Monte MJ; Marin JJ Clin Sci (Lond); 2001 May; 100(5):499-508. PubMed ID: 11294690 [TBL] [Abstract][Full Text] [Related]
25. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned? Erman A; Boner G; van Dijk DJ J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825 [TBL] [Abstract][Full Text] [Related]
26. Chronopathology for angiotensin converting enzyme circadian rhythm in migraine. Martelletti P; Cugini P; Letizia C; Di Palma L; Battisti P; Granata M; Scavo D; Giacovazzo M Chronobiologia; 1990; 17(1):59-64. PubMed ID: 2161725 [TBL] [Abstract][Full Text] [Related]
28. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma. Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214 [TBL] [Abstract][Full Text] [Related]
29. Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma. Miura N; Maruyama S; Oyama K; Horie Y; Kohno M; Noma E; Sakaguchi S; Nagashima M; Kudo M; Kishimoto Y; Kawasaki H; Hasegawa J; Shiota G Oncology; 2007; 72 Suppl 1():45-51. PubMed ID: 18087181 [TBL] [Abstract][Full Text] [Related]
30. [Variations in serum kininase II activity in acute jaundice]. Olivero S; Sciascia C; Mao P; Arione R; Enrichens F; Alberghina A; Festa T; Pessione E; Sanfelici G Minerva Med; 1986 May; 77(19):793-8. PubMed ID: 3012414 [TBL] [Abstract][Full Text] [Related]
31. [Re-examination of measurement of spectrophotometric assay for serum angiotensin I-converting enzyme activity and its clinical evaluation in various diseases]. Gotoh M; Mizuno K; Matsui J; Fukuchi S Nihon Jinzo Gakkai Shi; 1983 Feb; 25(2):121-30. PubMed ID: 6312141 [No Abstract] [Full Text] [Related]
32. Circadian rhythm of the angiotensin converting enzyme (ACE) activity in serum of healthy adult subjects. Veglio F; Pietrandrea R; Ossola M; Vignani A; Angeli A Chronobiologia; 1987; 14(1):21-5. PubMed ID: 3034521 [TBL] [Abstract][Full Text] [Related]
33. The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control study. Ay C; Bencur P; Vormittag R; Sailer T; Jungbauer C; Vukovich T; Mannhalter C; Pabinger I Thromb Haemost; 2007 Oct; 98(4):777-82. PubMed ID: 17938801 [TBL] [Abstract][Full Text] [Related]
34. [Clinical value of serum tissue polypeptide specific antigen detection for primary hepatic cancer]. Huang DR; Zuo Q; Cai HB; Zhang JY; Ji CY Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):89-92. PubMed ID: 15684008 [TBL] [Abstract][Full Text] [Related]
35. Des-gamma-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma. Tang W; Miki K; Kokudo N; Sugawara Y; Imamura H; Minagawa M; Yuan LW; Ohnishi S; Makuuchi M Int J Oncol; 2003 May; 22(5):969-75. PubMed ID: 12684661 [TBL] [Abstract][Full Text] [Related]
36. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma. Cui R; Wang B; Ding H; Shen H; Li Y; Chen X Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656 [TBL] [Abstract][Full Text] [Related]
37. [Relationship between serum angiotensin I-converting enzyme activity and diabetic nephropathy in patients with type II diabetes]. Liao L; Lei M; Han X; Chen H; Fan C Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):263-6. PubMed ID: 12016801 [TBL] [Abstract][Full Text] [Related]
38. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma. Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540 [TBL] [Abstract][Full Text] [Related]
39. [Intrinsic angiotensin II-generating system in human pancreatic cancer tissues]. Ohta T; Yi S; Amaya K; Kitagawa H; Kayahara M; Ninomiya I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Miwa K Gan To Kagaku Ryoho; 2002 Nov; 29(12):2325-8. PubMed ID: 12484065 [TBL] [Abstract][Full Text] [Related]
40. Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma. Cheng KS; Tang HL; Chou FT; Chou JW; Hsu CH; Yu CJ; Kao ST; Li TC Hepatogastroenterology; 2009; 56(93):1105-10. PubMed ID: 19760951 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]